Open-house rebate agreement for Leuprorelin

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Aug 03, 2027 · 340 days left·Open·Supplies·Framework

Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Leuprorelin, ATC L02AE02

62/100

Opportunity Score

Needs reviewMedium complexity

SuppliesFrameworkOpen

Why this score?

Opportunity

62 / 100

Complexity

58 / 100

Risk factors

Submitting through the wrong portal area is explicitly prohibited; the notice says contract documents must be submitted...

The monthly cut-off is strict: complete and correct documents must be received by the 3rd for the next month’s start, a...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Overview

Moderate opportunity

Key Facts

Framework procurement
Supplies contract
1 lot
Duration until Sep 2027
Non-exclusive open-house rebate agreements for Leuprorelin, ATC L02AE02.
Supply of pharmaceutical products under identical, non-individually negotiated contract terms.

Show full summary

Open-house supply arrangement for pharmaceutical rebate agreements on Leuprorelin (ATC L02AE02) in Germany, led by AOK Bayern. The notice states that this is not a competitive procurement: all pharmaceutical companies meeting the stated suitability requirement can join on identical, non-negotiable terms. No contract value is stated. Submission is via DTVP or by paper originals, with monthly cut-off rules for contract start dates.

Risks

Submitting through the wrong portal area is explicitly prohibited; the notice says contract documents must be submitted...

The monthly cut-off is strict: complete and correct documents must be received by the 3rd for the next month’s start, a...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

Only pharmaceutical companies may participate as potential contract partners.

Administrative

A signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.
The signed contract and the completed annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be submitted.

Buyer

Name

AOK Bayern - Die Gesundheitskasse

Location

München, DEU

[email protected]

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house rebate agreement for Leuprorelin

Open-house non-exclusive rebate agreement for the pharmaceutical product Leuprorelin (ATC L02AE02). Scope is supplies of pharmaceutical products. The lot information comes from structured data and the XML notice. Performance is in Germany, region DE212 (Bavaria/Munich area as buyer location, but place of performance is only given at country/subdivision level).

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Sep 2025 - Sep 2027

Procurement Details

Publication date: 13 Aug 2025
Languages: German

Reference metadata

Legal basis: 32014L0024

Reference IDs

Tender ID: 533423-2025

Documents (2)

Procurement document 1 Submission portal 1

Similar tenders

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3